These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN. Shen L; Suresh L; Malyavantham K; Kowal P; Xuan J; Lindemann MJ; Ambrus JL J Immunol; 2013 Jul; 191(2):608-13. PubMed ID: 23772034 [TBL] [Abstract][Full Text] [Related]
24. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome. Karnell JL; Mahmoud TI; Herbst R; Ettinger R Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930 [TBL] [Abstract][Full Text] [Related]
25. Cutaneous and Mucosal Manifestations of Sjögren's Syndrome. Generali E; Costanzo A; Mainetti C; Selmi C Clin Rev Allergy Immunol; 2017 Dec; 53(3):357-370. PubMed ID: 28871434 [TBL] [Abstract][Full Text] [Related]
26. Sjögren's autoimmunity: how perturbation of recognition in endomembrane traffic may provoke pathological recognition at the cell surface. Mircheff AK; Gierow JP; Yang T; Zhang J; Wood RL; Azzarolo AM; Warren DW; Zeng H; Guo Z; Kaslow HR; Hamm-Alvarez SF; Okamoto CT; Bachmann M J Mol Recognit; 1998; 11(1-6):40-8. PubMed ID: 10076804 [TBL] [Abstract][Full Text] [Related]
27. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren's syndrome. Pepose JS; Akata RF; Pflugfelder SC; Voigt W Ophthalmology; 1990 Dec; 97(12):1599-605. PubMed ID: 1965021 [TBL] [Abstract][Full Text] [Related]
28. Immune Response Targeting Sjögren's Syndrome Antigen Ro52 Suppresses Tear Production in Female Mice. Trzeciak M; Bagavant H; Papinska J; Deshmukh US Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261673 [TBL] [Abstract][Full Text] [Related]
29. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Jabs DA; Prendergast RA; Rorer EM; Hudson AP; Whittum-Hudson JA Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2567-71. PubMed ID: 11581200 [TBL] [Abstract][Full Text] [Related]
33. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome. Brayer JB; Cha S; Nagashima H; Yasunari U; Lindberg A; Diggs S; Martinez J; Goa J; Humphreys-Beher MG; Peck AB Scand J Immunol; 2001; 54(1-2):133-40. PubMed ID: 11439159 [TBL] [Abstract][Full Text] [Related]
34. Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Oak JS; Deane JA; Kharas MG; Luo J; Lane TE; Cantley LC; Fruman DA Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16882-7. PubMed ID: 17071741 [TBL] [Abstract][Full Text] [Related]
35. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Ariga H; Edwards J; Sullivan DA Clin Immunol Immunopathol; 1989 Dec; 53(3):499-508. PubMed ID: 2805454 [TBL] [Abstract][Full Text] [Related]
36. Lymphocyte migration to inflamed lacrimal glands is mediated by vascular cell adhesion molecule-1/alpha(4)beta(1) integrin, peripheral node addressin/l-selectin, and lymphocyte function-associated antigen-1 adhesion pathways. Mikulowska-Mennis A; Xu B; Berberian JM; Michie SA Am J Pathol; 2001 Aug; 159(2):671-81. PubMed ID: 11485925 [TBL] [Abstract][Full Text] [Related]
37. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjögren's syndrome. Zoukhri D; Hodges RR; Dartt DA Clin Immunol Immunopathol; 1998 Nov; 89(2):126-33. PubMed ID: 9787114 [TBL] [Abstract][Full Text] [Related]
38. Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren's syndrome. Szodoray P; Koczok K; Szanto A; Horvath IF; Nakken B; Molnar I; Zeher M Clin Rheumatol; 2008 Feb; 27(2):195-9. PubMed ID: 17713716 [TBL] [Abstract][Full Text] [Related]
39. Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome. Anderson LG; Tarpley TM; Talal N; Cummings NA; Wolf RO; Schall GL Clin Exp Immunol; 1973 Mar; 13(3):335-42. PubMed ID: 4573763 [TBL] [Abstract][Full Text] [Related]
40. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]